Healthy volunteers help test new tablet batches

NCT ID NCT07214922

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how the body absorbs and processes different manufacturing batches of an experimental tablet called evobrutinib. Twenty-eight healthy adults took a single dose of each batch, and researchers measured drug levels in the blood and checked for side effects. The goal was to see if the batches work the same way in the body, not to treat any disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Nuvisan GmbH

    Neu-Ulm, 89231, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.